ME Research UK is pleased to announce a worldwide call for applications from researchers wishing to investigate the causes, consequences and treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).
ME/CFS is a debilitating neurological disease, impacting several systems throughout the body, including the autonomic, neuroendocrine, immune and central nervous system. The majority of cases occur after an infection, especially viral infection, and impact all ages, races and social groups. Approximately 80% of cases are seen in females and a quarter of those with ME/CFS are housebound or bedbound. At present there is no diagnostic biomarker or effective treatment.
Funding is available to support scientifically robust biomedical studies and PhD positions at appropriate host institutions worldwide. Applications for pilot studies and seed-corn projects concerning novel aspects of ME research are particularly welcome.
We are happy to consider projects in all areas related to the biology or treatment of ME/CFS, but we are especially keen to receive applications in the following areas:
- Brain and nervous system (structural and functional changes)
- Immune system (autoimmunity and the role of specific autoantibodies)
- Diagnostic biomarkers
- Symptomatic impact of ME on other organ systems
- Gut microbiome
- COVID-19 and ME/CFS
The deadline for full grant applications is 13 November 2020.